We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

24 Feb 2024 - 28 Feb 2024
05 Mar 2024 - 07 Mar 2024

Rapid Sepsis Test Uses Magnetic Nanoparticles to Detect Bacterial Pathogens

By LabMedica International staff writers
Posted on 24 Aug 2023
Print article
Image: Magnetic nanoparticles (red) bind specifically to the spherical bacteria (yellow) (Photo courtesy of Empa)
Image: Magnetic nanoparticles (red) bind specifically to the spherical bacteria (yellow) (Photo courtesy of Empa)

When it comes to life-threatening blood poisoning caused by staphylococcus bacteria, quick identification of the bacteria in the bloodstream is vital to begin life-saving treatment. This urgency stems from the fact that staphylococcal sepsis results in fatality for up to 40% of cases. The infection, triggered by spherical bacteria, might initially manifest as a local skin ailment or pneumonia. However, when staphylococci infiltrate the bloodstream during sepsis, severe complications can emerge. In such critical scenarios, prompt identification of pathogens and selection of suitable antibiotics are vital. This is especially crucial as Staphylococcus aureus strains can exhibit resistance to multiple antibiotics. Researchers have now developed "sepsis sensors" using magnetic nanoparticles that enable rapid detection of bacterial pathogens and identification of appropriate antibiotic candidates.

Researchers at Empa (Dübendorf, Switzerland), along with their colleagues from ETH Zurich (Zürich, Switzerland), looked for a way to bypass the lengthy intermediate step of first cultivating the bacteria in a blood sample for a diagnostic procedure. They developed a method utilizing magnetic nanoparticles that are capable of binding to staphylococci. Consequently, these bacteria can be identified through the application of a magnetic field. Subsequently, antibiotic sensitivity is assessed using a chemiluminescence technique. If antibiotic-resistant bacteria are present in the sample, it emits light. Conversely, if the bacteria can be eradicated with antibiotics, the reaction vessel remains dark.

Another problematic bacterial entity is Pseudomonas aeruginosa, a rod-shaped bacterium capable of causing various illnesses, including urinary tract infections via catheterization during hospital stays. Such infections can develop into sepsis, and these pathogens are often resistant to numerous antibiotics. In such cases, magnetic nanoparticles offer the distinct advantage of versatility. The approach can be customized for different bacteria types, similar to a modular system. This adaptability enabled the researchers to design a rapid "sepsis sensor" leveraging magnetic nanoparticles. In samples containing synthetic urine, this method reliably identified bacterial species and gauged potential antibiotic resistance through chemiluminescence reactions. So far, the researchers have assessed their magnetic nanoparticle toolkit for sepsis and urinary tract infections using laboratory samples. In the coming phase, the team plans to validate the sepsis tests alongside their clinical partners by analyzing patient samples.

"All in all, the sepsis test takes around three hours – compared to several days for a classic cultivation of bacterial cultures," said Empa researcher Fei Pan.

Related Links:
Empa 
ETH Zurich 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Wireless Point-of-Care Testing for Hepatitis B Virus (Photo courtesy of Chulalongkorn University)

Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step

Hepatitis B, a significant global health concern, is responsible for chronic liver diseases like cirrhosis and liver cancer which is one of the most common cancers worldwide. The challenge with hepatitis... Read more

Molecular Diagnostics

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome

Antiphospholipid syndrome (APS) is an autoimmune disorder that typically presents as venous or arterial thrombosis and/or pregnancy loss. Diagnosing APS can be difficult as its symptoms often resemble... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Pathology

view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more

Industry

view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.